TickerKhojComparison · NSE · data 2026-11-02
Vaishali Pharma Ltd. vs Vilin Bio Med Ltd.
In plain words
Size: Vaishali Pharma Ltd. is about 1.2 times the market value of Vilin Bio Med Ltd..
Valuation (P/E): Vilin Bio Med Ltd. 38.9 vs Vaishali Pharma Ltd. 20.
Return on equity: Vilin Bio Med Ltd. 7.5% vs Vaishali Pharma Ltd. 6.2%.
Profit growth over 3 years: Vilin Bio Med Ltd. 15.7% a year vs Vaishali Pharma Ltd. -14.2% a year.
Debt to equity: Vaishali Pharma Ltd. 0.27 vs Vilin Bio Med Ltd. 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| VAISHALI | VILINBIO | |
|---|---|---|
| Price | ₹6.55 | ₹49.5 |
| Market cap | ₹87 cr | ₹73 cr |
| P/E | 20 | 38.9 |
| P/B | — | 2.7 |
| ROE | 6.2% | 7.5% |
| ROCE | 3.6% | 11.3% |
| Debt / equity | 0.27 | 0.01 |
| Operating margin | 3.4% | 6.9% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 15.8% | 50.8% |
| Profit growth, 3 years (yearly) | -14.2% | 15.7% |
| 1-year return | -36.1% | 87.1% |
| Revenue, last 12 months | ₹108 cr | ₹42 cr |
| Net profit, last 12 months | ₹4 cr | ₹2 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹2 cr | — |
| Quarter profit vs a year earlier | +21.1% | — |
| Promoter holding | 31.61% | — |
| Health check | Average (5.2/10) | Strong (7.5/10) |
Common questions
Which has a higher P/E, Vaishali Pharma Ltd. or Vilin Bio Med Ltd.?
Vilin Bio Med Ltd. trades at the higher P/E (38.9 against 20). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Vilin Bio Med Ltd. (7.5% against 6.2%).
Which carries more debt?
Vaishali Pharma Ltd. has the higher debt-to-equity ratio (0.27 against 0.01).